Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Brain Neoplasms 6Prostatic Neoplasms 2Cognitive Dysfunction 2Breast Neoplasms 2Tobacco Use Disorder 1Recurrence 1Rectal Neoplasms 1Neoplasms, Germ Cell and Embryonal 1Motor Activity 1Lung Neoplasms 1Glioblastoma 1Ependymoma 1Craniopharyngioma 1Colorectal Neoplasms 1Colonic Neoplasms 1Carcinoma, Non-Small-Cell Lung 1Carcinoma, Hepatocellular 1Breast Cancer Early Stage Breast Cancer (Stage 1-3) 1

Interventions

Exercise 12Methods 2Diet 2Behavior Therapy 2secukinumab 1peficitinib 1lime 1cytisine 1Waiting Lists 1Telemedicine 1Spirometry 1Self-Management 1Resistance Training 1Professional Autonomy 1Nutrition Assessment 1Metformin 1Memantine 1High-Intensity Interval Training 1Hematologic Tests 1Health 1Exergaming 1Diet Therapy 1Counseling 1Clinical Trials as Topic 1Aspirin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Motor Activity × Memantine × Clear all
NCT06727773 2026-05-06

Memantine and Exercise to Improve Cognitive Function and Modulate Biological Pathways of Cognitive Decline During Chemotherapy in Breast Cancer

UNC Lineberger Comprehensive Cancer Center

Phase 2 Recruiting
90 enrolled
Breast

Breast Neoplasms, Motor Activity, Cognitive Dysfunction

Data powered by HemOnc (CC BY 4.0) Colophon âš¡